KRAS-G12C Mutation Is Associated with Poor Outcome in Surgically Resected Lung Adenocarcinoma-Reference-Cited by-同舟云学术

KRAS-G12C Mutation Is Associated with Poor Outcome in Surgically Resected Lung Adenocarcinoma

Published:2014-10 Issue:10 Volume:9 Page:1513-1522
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Nadal Ernest,Chen Guoan,Prensner John R.,Shiratsuchi Hiroe,Sam Christine,Zhao Lili,Kalemkerian Gregory P.,Brenner Dean,Lin Jules,Reddy Rishindra M.,Chang Andrew C.,Capellà Gabriel,Cardenal Felipe,Beer David G.,Ramnath Nithya

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference47 articles.

1. Somatic mutations affect key pathways in lung adenocarcinoma;Ding;Nature,2008

2. ras oncogenes in human cancer: a review;Bos;Cancer Res,1989

3. Frequency and spectrum of mutations at codons 12 and 13 of the c-K-ras gene in human tumors;Capella;Environ Health Perspect,1991

4. Frequency and distinctive spectrum of KRAS mutations in never smokers with lung adenocarcinoma;Riely;Clin Cancer Res,2008

5. KRAS mutations in non-small-cell lung cancer and colorectal cancer: implications for EGFR-targeted therapies;Maus;Lung Cancer,2014

Cited by 105 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multiscale calculations reveal new insights into the reaction mechanism between KRASG12C and α, β-unsaturated carbonyl of covalent inhibitors;Computational and Structural Biotechnology Journal;2024-12

2. Additional impact of genetic ancestry over race/ethnicity to prevalence of KRAS mutations and allele-specific subtypes in non-small cell lung cancer;Human Genetics and Genomics Advances;2024-07

3. Clinical characteristic and survival outcomes of patients with advanced NSCLC according to KRAS mutational status in the French real-life ESME cohort;ESMO Open;2024-06

4. Assessing the prognostic value of KRAS mutation combined with tumor size in stage I-II non-small cell lung cancer: a retrospective analysis;Frontiers in Oncology;2024-05-31

5. Prolonged Cancer Control With Adagrasib in Patients With Metastatic, KRAS-Mutated NSCLC After Sotorasib-Induced Hepatotoxicity: A Case Report;JTO Clinical and Research Reports;2024-04